Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)

Overview

About this study

This study is designed to investigate whether the treatment of non-anemic iron deficiency with intervenous iron sucrose will result in decreased symptom reporting and improved cardiovascular indices in adolescents (age 12-18) with Postural Orthostatic Tachycardia Syndrome (POTS).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria

aged 12-21 years
chronic (>3 months)symptoms of orthostatic intolerance (including but not limited to lightheadedness, syncope, headache, fatigue, weakness, sweating, nausea and palpitations)
symptomatic orthostatic heart rate increase of greater than or equal to 40 beats per minute during a 10 minute 70 degree head up tilt study
presence of non-anemic iron deficiency, defined as serum ferritin level less than or equal to 20 mcg/L with normal hemoglobin

Exclusion criteria

orthostatic hypotension within 3 minutes of 70 degree head up tilt
pregnant or lactating females
presence of other organ failure or systemic illness that can affect autonomic function
concurrent medication therapy with anticholinergic, alpha-adrenergic antagonists, beta-adrenergic antagonists unless medication is held for five half-lives prior to study
laboratory evidence of significant anemia, as defined by a hemoglobin level 1 gm/dL or more below the normal reference range for the patient’s age and gender,
Iron overload
personal history of hematochromatosis or first degree relative with hematochromatosis
known sensitivity to Venofer (TM) or other intravenous iron preparations

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Amie Jones, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Amie Jones, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials